Miravirsen works against hepatitis C virusBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2069 (Published 03 April 2013) Cite this as: BMJ 2013;346:f2069
Hepatitis C virus is dependant for growth on microRNA-122 in the liver of infected people. A new drug, miravirsen, binds to microRNA-122, disabling the binding and growth of the virus.
A phase IIa study tested three …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial